Last reviewed · How we verify
Droxone (algestone acetophenide)
Droxone (generic name: algestone acetophenide) is a algestone acetophenide drug. It is currently in unknown development.
Droxone works by binding to and activating glucocorticoid receptors, mimicking the effects of cortisol in the body.
Droxone, also known as algestone acetophenide, is a small molecule drug of the algestone acetophenide class. Its original development is attributed to an unknown entity, and its current ownership is also unclear. The target and indications for Droxone are not specified, and its commercial status, including FDA approval and patent status, is unknown. As a result, there is limited information available on its pharmacokinetic properties, such as half-life and bioavailability. Further research is necessary to determine the safety and efficacy of Droxone.
At a glance
| Generic name | algestone acetophenide |
|---|---|
| Drug class | algestone acetophenide |
| Therapeutic area | Immunology |
| Phase | unknown |
Mechanism of action
Imagine your body has a special lockbox that regulates inflammation and immune responses. Droxone is a key that fits into this lockbox, allowing it to send signals that reduce inflammation and suppress the immune system. This can help to treat conditions characterized by excessive inflammation or immune activity.
Approved indications
Common side effects
- Lupus nephritis
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Droxone CI brief — competitive landscape report
- Droxone updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Droxone
What is Droxone?
How does Droxone work?
What is the generic name of Droxone?
What drug class is Droxone in?
What development phase is Droxone in?
What are the side effects of Droxone?
Related
- Drug class: All algestone acetophenide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Immunology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing